PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Chart, page-4226

  1. 7,655 Posts.
    lightbulb Created with Sketch. 6934
    Unless a partnership or rumour of announced, this could be sold down further on EOFY selling late into June (to state the obvious) - and I will be buying more if so.

    No one ever remembers the long-term holders who held for years and finally sold out, when these things rise from the ashes. Just celebrate the save by the CEO forgetting his long-term under performance.

    At these prices PR cannot strongly negotiate a strong deal even if he does get one. Any joint venture partner more likely to walk away and consider a takeover. An easy $200 million takeover would get you to the negotiating table, so if PR demands silly things like $50 million upfront and $100 million in milestone payments (that he might have when it was trading $2) for example, any sensible suitor would surely think of taking it all for not much more.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.